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Recovery is a multidimensional concept, including symptomatic, functional, social,
as well as personal recovery. The present study aims at exploring psychosocial
and biological determinants of personal recovery, and disentangling time-dependent
relationships between personal recovery and the other domains of recovery in a sample
of people with a psychotic disorder. A cohort study is conducted with a 10-year follow-up.
Personal recovery is assessed using the Recovering Quality of Life Questionnaire (ReQoL)
and the Individual Recovery Outcomes Counter (I.ROC). Other domains of recovery
are assessed by the Positive and Negative Symptom Scale Remission (PANSS-R),
the BRIEF-A and the Social Role Participation Questionnaire—Short version (SRPQ) to
assess symptomatic, functional and societal recovery, respectively. In addition, multiple
biological, psychological, and social determinants are assessed. This study aims to
assess the course of personal recovery, and to find determinants and time-dependent
relationships with symptomatic, functional and societal recovery in people with a
psychotic disorder. Strengths of the study are the large number of participants,
long duration of follow-up, multiple assessments over time, extending beyond the
treatment trajectory, and the use of a broad range of biological, psychological, and
social determinants.
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INTRODUCTION
The course of personal recovery among people with a psychotic disorder is largely unknown since
this a relatively new concept not included in long-term cohort studies. The present study aims
to find determinants of personal recovery, and disentangle time-dependent relationships among
personal and other dimensions of recovery and its determinants over a 10-year period. Based on
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DutchMental Health Care reports (1–4), recovery can be defined
as a four-dimensional framework. This framework consists of
personal, symptomatic, societal, and functional recovery, with
personal recovery at the center (Figure 1). The dimensions of
recovery are thought to be related to one another, but could also
be independently achieved (2).
Personal Recovery
Personal recovery from mental illness is a construct that has
gained increased attention over the past thirty years (5). Since
the early nineties, participants in the debate on recovery from
serious mental illnesses have underlined the notion that personal
recovery from a psychotic disorder can occur, either with (6–8)
or without psychiatric symptoms being present (9). This is in
line with the narratives of people who have experienced mental
health issues and used mental health care services (8). It is now
acknowledged in mainstream parts of mental health care that
mental illnesses should be seen as vulnerabilities, not as a disease
that can be cured (10). However, in many studies, those who have
remaining symptoms are still considered to be non-recovered
(11). Due to the different definitions and ideas used in research
and the new line of thought in mental health care, there remains
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confusion about the concept of personal recovery among clients,
their families, clinicians, policy makers and researchers (12).
Furthermore, it remains unclear how different factors influence
both short- and long-term personal recovery in schizophrenia
and other psychotic disorders after treatment (13). There is,
however, some consensus on what elements the concept of
personal recovery consists of. Publications show that personal
recovery should be person-centered, re-authoring, based on
exchange, and within the community (14). In line with this
analysis, the Slade group stated that (15) personal recovery refers
to an individual process of adaptation and development where
one does not simply return to, but rather grows beyond the
premorbid self.
Slade et al. developed the CHIME conceptual framework for
recovery, which identifies five processes that constitute personal
recovery: Connectedness, Hope and Optimism, Identity,
Meaning in life, and Empowerment (16). However, the CHIME
framework has been criticized for being overly optimistic. The
difficulties that arise during personal recovery are neglected, as is
the influence of therapeutic input. Therefore, the more extensive
framework CHIME-D, with the D for “difficulties” (17), has been
proposed. However, the specific content of personal recovery,
the process is dynamic and non-linear with both gains and
relapses (6). A dimension of recovery which should therefore be
exclusively client-rated (18).
Symptomatic Recovery
Symptomatic recovery from psychosis is one of the secondary
outcomes in this study, alongside functional and societal
recovery. Symptomatic recovery in psychotic illnesses is
about reducing positive and negative symptoms (19) using
objective, reliable measures (20). A recent analysis showed that
symptomatic recovery is constructed from both client-rated and
staff-rated factors (18, 21, 22), with health care professionals
being leading when deciding which path to take.
Functional Recovery
Functional recovery focuses on whether someone is capable
to recover or compensate for the loss of skills (23). People
with schizophrenia may score lower on several dimensions of
cognition, like memory, concentration and attention, compared
to healthy controls (24, 25), either due to deterioration or
impaired development. Especially impairment in executive
functions like planning, self-control, and other self-regulating
functions (26) can have a major negative impact on one’s daily
functioning, career, education or social life.
Societal Recovery
Lastly, societal recovery focuses on counteracting the public
stigma on mental illness and improve the position and rights
of (ex-)clients within society (20). In this study, we focus on
the position of clients in their own social environment by
studying how important they find the different social roles
and the difficulties they encounter in performing these roles.
Furthermore, societal recovery also includes measures on quality
of housing, work, education, and social relationships (2). People
with SMI often experience difficulties in finding employment and
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FIGURE 1 | Four dimensional framework of Recovery (2).
report some form of social exclusion and broken relations with
family and friends (27) often due to the stigma of being perceived
as dangerous (28–30).
In this four-dimensional framework of recovery, every
domain has its own course and characteristics as well as
interactions with other domains. Personal recovery is positioned
at the center, given it’s close connection to the client’s
own narrative of their own life-course (2). In the present
study this multidimensional concept of recovery will be used
to try to disentangle the determinants of (the course of)
personal recovery.
Determinants of (Personal) Recovery
Although personal recovery is thought to be the most central and
important, the four dimensions may be determined by similar
factors. Therefore, we will discuss groups of determinants (i.e.,
biological, psychological, and social) that may be related to all
four dimensions of recovery.
Biological Determinants
Age, genetic factors (12, 31), poor physical health, sleep
dysfunction, (32) and drug and alcohol use during illness (33)
may have an effect on all dimensions of recovery (34–36).
These dysfunctions have been linked to poor quality of life (31)
and to severity of symptoms (37). The hypothesis is that poor
physical health and sleep dysfunction or delay negatively affect
the dimensions of recovery. How, and to what extent, these
biological factors influence recovery, is dependent on the specific
determinant and dimension of recovery.
Psychological Determinants
Trauma
People with a severe mental illness (SMI) have a higher risk
of being traumatized, or become a crime victim (38, 39). For
example, both physical and emotional neglect and complex PTSD
are highly prevalent in this group (40, 41), especially if a person is
also intellectually disabled (42). Furthermore, trauma is thought
to have both a direct and indirect negative effect on the onset
and symptomatic course of psychotic disorders (43). Therefore,
early childhood trauma, recent victimization, and traumatic
experiences of the illness itself and during the course of the
illness are expected to have a negative impact on all dimensions
of recovery.
Cognitive Function
Cognition is an umbrella term used to describe multiple
mental skills, including learning, memory, problem solving,
reasoning, attention, and decision making (44). It is known that
impaired cognition is both a predictor for poor outcome in
schizophrenia as well as a consequence (45). More specifically,
having poor memory is a risk factor for the development of
schizophrenia, whereas having a higher verbal IQ is a protective
factor (46). During the illness, general cognitive functioning
is lower for people with schizophrenia compared to healthy
controls (25). Approximately 40% of People with a SMI are
suspected to have an intellectual disability (42, 47), with a
decreased cognitive flexibility (i.e., mentally switching between,
or adapting to different tasks or stimuli) as a consequence.
This negatively influences the course of recovery (48). Likewise,
illness-insight–partly predicted by cognitive abilities (49)–and
treatment compliance (50) are predictors of the course of
the illness (50). It is therefore expected that overall cognitive
functioning not only predicts better functional recovery, but also
better symptomatic and societal recovery.
Personality Traits
Psychopathological personality traits can be identified in people
with proneness to psychosis (51). These traits are related to the
Frontiers in Psychiatry | www.frontiersin.org 3 January 2021 | Volume 11 | Article 609530
van Aken et al. UP’S Cohort Study on Recovery
five major categories of personality (i.e., openness, extraversion,
conscientiousness, agreeableness, and neuroticism) (52), which
are found to influence well-being (53). This goes especially for
neuroticism, since adolescents with higher neuroticism scores
are at higher risk for developing psychotic symptoms (54, 55).
Therefore, it is hypothesized that traits of neuroticism will also
negatively affect the process of personal recovery.
Empowerment and attachment
Self-esteem, resilience, hopelessness and empowerment (16) are
all shown to correlate with Quality of Life measures (56).
Furthermore, spirituality, self-esteem (57), attachment (58, 59)
and positive social support are thought to contribute to all
dimensions of recovery (60). Due to these findings, along with the
prominent place empowerment has in the CHIME framework
(16), it is believed that the more empowered participants are,
the more likely they are to further their personal recovery.
Furthermore, the ability to securely attach and thus build
personal bonds with those around, is hypothesized to influence
personal, functional, symptomatic and societal recovery in a
positive manner.
Social Determinants
Social capital is thought to be a (health) resource (61), which has
cognitive and structural components (62). Cognitive components
of social capital are associated with mental health (63) and
levels of experienced discrimination (64). The structural part
of social capital is derived from social contacts and social
participation (65). Social participation thus has an influence
on individual health (61), self-reported health (66), and social
functioning (67), and is likewise expected to contribute positively
to (societal) recovery.
Social Factors
Many people with a psychotic disorder suffer from stigmatization
and social exclusion (68). For example, public and internalized
stigma have been associated with lower levels of perceived social
support, recovery, and quality of life (57, 69) and stigma in
general is associated with harmed self-esteem (57). Other social
factors, including employment and income, contribute to the size
of social networks, and the number of social relationships (70), as
does living with a partner or as part of a family (71). Clients often
define their problems not only in terms of pathology, but also
in social terms such as failed friendships, careers, or loneliness
(72). Furthermore, employment is positively linked to a health-
related quality of life (73). Mental health difficulties like low
income, unemployment (74) or poor housing (75) may on the
other end act as barriers to social inclusion (76, 77). There is
also evidence that suggests migration or ethnic minority status
is associated with an inferior social position, which may add to
the risk of developing a psychotic disorder (78). Participation and
social functioning can thus all influence dimensions of recovery
in a positive manner (26), since having one or more social
relationships and a wider social network is thought to be critical
for achieving recovery (79).
Given all these findings we expect that when high internalized
stigma is present, empowerment will be low. Likewise, when there
is high internal stigma, recovery—especially personal and societal
recovery—will be slower and with more downs. Furthermore,
it is hypothesized that when someone is employed, this will
positively contribute to societal and personal recovery, as do
high(er) income and no debts.
Treatment Related Determinants
Evidence-based mental health care with treatment related factors
including pharmacological and psychosocial treatments, aim at
improving outcome. Therefore, (adherence to) treatment may be
an important determinant of outcome. In addition, the number
of psychotic relapses and hospitalisations have been associated
with outcome.
Study Objectives
The primary aim of this cohort study is to investigate the
proportion of clients who increase on the primary outcome
measure of personal recovery over time. Secondary objectives
include investigating the proportion of clients who increase
on measures of symptomatic, functional and societal recovery
over time. Other aims include exploring interactions and
time-dependent relationships between the four dimensions
of recovery. Furthermore, to explore different effects of
determinants, we measure biological (somatic functioning, sleep,
drug abuse), psychological (diagnosis, personality traits, anxiety,
depression, adverse childhood experiences, trauma, attachment,
cognition, social cognition, illness insight, empowerment,
resilience), social parameters (internalized stigma and disability
in functioning), and treatment related factors (psychosocial
treatments and medication). Another secondary objective is
identifying how these determinants and their interactions may
influence the four dimensions of recovery over time.
Whereas, most studies have focused on only a few episodes
of recovery (80), the relatively extensive follow-up period
of the current study will make it possible to observe more
episodes of recovery over time. Furthermore, most previous
research only focused on one aspect or dimension of recovery
(81), undermining the complex and multidimensional nature
of recovery.
By including all the above-mentioned aspects of a participant’s
life, this study eventually aims to identify mechanisms which
in the end can be translated into (the adaptation of existing)
interventions which support clients in their recovery processes.
METHODS/DESIGN
Study Design
The current study is a multicentre, longitudinal cohort study
on recovery from psychotic disorders. The study has a
10-year follow-up period for participants diagnosed with a
psychotic disorder.
Setting
In order to test 600 participants every year, multiple centers
in the Netherlands are participating in this study. Every center
has multiple facilities, which give care to people with early
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psychosis and/or reoccurring psychosis. These facilities can either
be outreaching or a clinical setting.
Data Collection
To test all participants, student-researchers will participate in
each team and/or facility involved in this study. These student-
researchers are MSc student in psychology, medicine or health
sciences for whom this study is part of their research internship.
They will be trained beforehand and are tasked with informing
clients about the study, asking them to participate, including
them in the study, interviewing them, processing the data and
writing a report for the practitioners. As part of this team, they
will sign a confidentially agreement, as is standard in Dutch
mental health care. Furthermore, they receive access to the
Electronic Patient Files (EPF).
Recruitment and Consent
Clients will be selected through a search in the EPF of the
participating Mental Health Care Institutions. An anonymised
list of all clients within a team will be made by the institution.
All those not eligible to participate in this study based on the
inclusion criteria, will be filtered out. Of the remaining list, 30
clients will be randomly selected. The student-researcher and the
teamwill then receive this list of clients to ask them to participate.
Their primary practitioner within the mental health care team is
thus aware which clients will be asked to participate and is able
to identify those still in active psychosis who are thus unable to
participate at that moment. Furthermore, the practitioner can
already prepare the client on the visit of the student-researcher,
who will be responsible for data collection.
After student-researchers and participants are introduced to
one another by the primary practitioner, the first appointment
will be made in which the client will be fully informed on the
study by the student, and the client will receive the subject
information sheet. When all questions are answered, participants
are given 2 weeks to consider their participation. If they like
to participate, they will be asked to sign an informed consent
(IC), of which they will receive a copy. The IC involves consent
for feedback to the practitioner, access to the EFP files and
using the collected data for research. These are mandatory to
participate in the study. Furthermore, the participant is given
the option to consent to the study using contacts of choice
and using the municipal address database (in Dutch: GBA)
when contact through available personal information fails. After
the IC is signed, the main health care practitioner will be
informed, after which an appointment will bemade to include the
participant in the cohort. For follow-up assessments, participants
are contacted via personal details listed in the EPF. These entail
name, surname, maiden name if applicable, date of birth, initials,
address, e-mail address and, if consented to, the contact details of
two contacts given by the participant. As mentioned earlier, these
contact details will only be used if researchers fail to establish
contact during follow up, which will most likely be the case
when participants are no longer in mental health care or have
moved to a different region. Given the aim of the study, those
recovering over time are still asked to participate, even though
they are referred back to their general practitioner. Likewise,
some participants who are worsening over time might lose
touch with mental health care. These participants will also be
followed-up for the duration of the study. If at any follow-up
measurement the participant is unable to participate, e.g., due
to active psychosis or incarceration, the measurement will be
postponed. However, if a measurement has not been carried out
within 9 months, the measurement will fall through and the next
measurement will become the objective.
Moreover, measures will be taken to minimize drop-out rates
and to increase participant motivation to take part in follow-up
interviews. These include sending participants optional birthday
cards and regular updates via newsletters and social media
channels. Researchers will also regularly visit the cooperating
mental health care facilities and participate in any relevant
events. Lastly, researchers will regularly evaluate reasons why
clients decline participation in order to adjust recruitment
strategies accordingly.
Participants
The research population will consist of clients who receive
treatment for a first episode psychosis or have a diagnosis
of schizophrenia or another psychotic disorder (schizoaffective
disorder, delusional disorder, psychosis not otherwise specified)
and who are between 18 and 65 years old. They will be
recruited at different Mental Health Care centers in various
teams specialized in in- and outpatient care for severe mental
illnesses. Furthermore, they all should be able to give informed
consent (IC). The aim is to include both clients diagnosed with
early psychosis and chronic psychosis. Early psychosis patients
are those who have had psychotic symptoms no longer than
5 years. Psychoses are considered chronic, when the psychotic
symptoms are present for 5 or more years. Clients who have




Main study parameter will be scores on two scales assessing
personal recovery, measured by the 10-item ReQOL (82) and
the I.ROC (83). An overall index score for the ReQOL can be
calculated by summing the numbers for the 10 questions where
0 indicates poorest and 40 indicates the highest quality of life.
The reliability (internal consistency) in patient samples for the
ReQoL-10 is shown to be high (α = 0.85) (82). The I.ROC
consists of four dimensions. Three questions are asked on the
dimensions of empowerment, home, people and opportunity.
The scores range from 0 to 6 per question. The internal
consistency is shown to be high (α = 0.86).
Additionally, the Dutch ReQoL-10 will be validated during
the course of the study, allowing the construction of normal
distribution tables on which cut-off scores for personal recovery
will be based.
Secondary Outcome Measures
Secondary outcome measures include symptomatic recovery as
assessed by the Positive and Negative Symptom Scale–Remission
(PANSS-R; α = 0.80) (84). Level of functional recovery will
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be assessed using the BRIEF-A (self-rated; functional recovery;
α = 0.96) (85), and level of social recovery will be assessed using
the Social Role Participation Questionnaire [SRPQ; self-rated;
social recovery; (86)] over time. The SRPQ has not yet been
tested in a psychiatric population, but has been shown to be
valid and reliable among patients with Ankylosing Spondylitis
(AS) (87). To distinguish levels of symptomatic recovery, the
Andreasen remission criterium (88) will be used for the PANSS-
R, which states that symptoms are in remission when a score
of “mild”/“three” is observed for all eight items, for 6 months.
The PANSS-R will only be administered every year, so it will
be necessary to deviate from the time threshold of 6 months.
Cut-off scores for functional and social recovery will be based
on normal distribution tables from the BRIEF-A (89) and the
SRPQ, respectively, in which (sub)clinical levels of functional
and social recovery can be identified. Psychiatric history and




Somatic health will be assessed using the Physical Complaints
Questionnaire (in Dutch: Lichamelijke Klachten Vragenlijst-51)
(91) and the Treatment Inventory of Costs in Patients with
psychiatric disorders (TIC-P; α = 0.83) (92). Subsequently, sleep
(patterns) will be measured through the Pittsburgh Sleep Quality
Index (PSQI; α = 0.83) (93). Furthermore, substance abuse
will be assessed using the Addictions for Triage and Evaluations
questionnaire (MATE; α = 0.75–0.92) (94). A standard physical
examination (PE) is done every year in people with both early and
chronic psychosis. During these physical checks, length, weight,
abdominal girth and blood pressure are measured. Furthermore,
a case report form containing questions about age, gender,
medication, lifetime psychiatric illness diagnosis and psychiatric
history (including number of compulsory admissions) will be
filled in as well.
Psychological Determinants
Intellectual disability will be screened using the Screener for
Intelligence and Learning Disabilities (SCIL), which has been
shown to have good internal consistency (Cronbach’s α = 0.83)
(95). Depression and anxiety will be screened using the Patient
Health Questionnaire-9 (PHQ-9; α = 0.89) (96) and Generalized
Anxiety Disorder-7 (GAD-7; α = 0.92) (97) screening scales.
Impaired cognition will be assessed using the Brief Assessments
Cognition in Schizophrenia (BACS; α > 0.79 for all subtests) (24)
and the social cognitive tasks will be the Picture Arrangements
(98, 99) and the Hinting Task (100). Furthermore, personality
traits, trauma, early childhood trauma and attachment will
be assessed using the NEO-Five Factor Inventory (NEO-FFI;
α = .88) (101), Trauma Screening Questionnaire (TSQ; AUC =
0.85) (41), Adverse Childhood Experience questionnaire (ACE;
α = 0.76) (102, 103)and the Psychosis Attachment Measure
(PAM; attachment anxiety α = 0.82 and attachment avoidance
α = 0.76) (104), respectively.
Psychological processes like coping, resilience, empowerment,
insight and therapy compliance will be assessed over time with
the Coping Inventory in Stressful Situations (CISS; α = 0.86)
(105, 106), Brief Resilience Scale (BRS; α = 0.83) (107, 108),
Dutch Empowerment List (NEL; α = 0.94) (89), Brief Cognitive
Insight Scale (BCIS; α= 0.60–0.68) (109) and Therapy adherence
Scale (SES; α = 0.91) (110). Internalized stigma will be assessed
using the ISMI-10 (α = 0.94) (111, 112).
Social Determinants
Social factors like education, work and work-history will
be registered, along with administering the World Health
Organization—Disability Assessment Schedule 2.0 (WHO-
DAS 2.0; α = 0.95) over time (113). Basic social capital
demographics, family history, socio-economic status, living
situation, family composition, working situation, and incomewill
also be enquired.
Assessment of Treatment Related Factors
Prescribed medication and psychosocial treatments will be
assessed form the electronic patient files.
Questionnaires and Instruments
An overview of all themeasurements is given inTable 1. The time
for each questionnaire is also listed. When questionnaires are
filled in afterwards by the researcher, and thus does not involve
the participants involvement, the time is listed between brackets.
All primary and secondary outcome measures will be assessed
every year. All other questionnaires and procedures will be
repeated every 2 years, with the last measurement 10 years after
baseline. Table 2 shows which questionnaires will be assessed
over time. All questionnaires and procedures baseline will be
assessed through a face-to-face interview at the participants home
or at the health-care institution. Follow-up measurements can be
done either face-to-face, over the phone, or via a combination
of both. In both instances, the questionnaires can be spread out
over multiple appointments in order to make sure the participant
is able to answer all questions as is, without weariness or
diminished attention getting in the way. Furthermore, this set-up
also decreases the burden of the long and vast interview. Both the
number of appointments and the location of the appointments
are dependent on the preference of the participant. In some cases,
face-to-face interviews in which the questionnaires will be read
out loud and explained will be necessary andmandatory. This can
be the case for e.g., participants with a possible learning disability.
Student-researchers are trained to do so without changing the
content of the questionnaires and without nudging participants
to a certain answer.
Furthermore, a yearly physical examination (length, weight,
abdominal circumference and blood pressure) and blood test
(Hemoglobin, leukocytes and differentiation, renal function, liver
function, triglycerides, HDL-cholesterol, prolactin, glucose) are
gathered from the EPF. Since these are standardized care in this
patient population in the Netherlands, and participants consent
to gathering this information via their general practitioner while
they are still receiving care. Participants receive a compensation
of 25 euros for each completed measurement.
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TABLE 1 | Questionnaires and instruments.
Parameters Test Time (min)
Primary Personal Recovering quality of life, short version 10 items (self-rated). 5
outcome recovery Individual recovery outcome counter (self-rated) 10
Secondary Symptomatic
recovery
Positive and negative symptoms scale—remission (observer-rated) 10
Outcomes Functional
recovery
Behavior rating inventory of executive function—adult version (self-rated) 15
Societal
recovery
Social role participation questionnaire—short form (self-rated) 10
Determinants Biological Physical complaints questionnaire 51 (in Dutch: Lichamelijke klachtenvragenlijst 51; self-rated) [30]
15
Questionnaire on healthcare utilization and productivity losses in patients with a psychiatric disorder
(self-rated)
10
Pittsburgh sleep quality index (self-rated) 5
Psychological Opcrit+ [45]
Screener for Intelligence and mental challenge (in Dutch: screener voor intelligentie en licht
verstandelijke beperking, SCIL; observer-rated)
10
NEO—five factor inventory (self-rated)
Patients Health Questionnaire—Depression Scale (self-rated)




Adverse childhood experience (observer rated) 3
Trauma screening questionnaire (self-rated) 5
Measurements in the addictions for triage and evaluations part 1 & 4 (observer rated) 10
Psychosis attachment measure (self-rated) 10
Brief assessment of cognition in schizophrenia (observer-rated) 35






Coping inventory for stressful situations (self-rated) 10
Beck cognitive insight scale (self-rated) 10
Netherlands empowerment list—short version (in Dutch: Nederlandse empowerment lijst; self-rated) 10
Brief resilience scale (self-rated) 3
Internalized stigma of mental illness, short version (self-rated) 10
Social WHO-DAS 2.0 (observer-rated) 20
Other Routine monitoring outcome (self-rated) [15]
Mental health—cluster index test (In Dutch: GGZ kluster indicatoren toets; observer rated) [15]
Integrated recovery list (in Dutch: Integrale herstel lijst; observer/self- rated) [15]
Service engagement scale [15]
Treatment overview (including medication) [30]
Observations and Assessment Results
Observations and/or assessment results might be relevant for
current care. Furthermore, some topics might reveal thoughts
or actions which can be harmful to the participant or their
environment, but which are not known by the practitioner.
Therefore, all results are reported back to the mental health care
team which gives care to the participant.
Patient Involvement
Service users/experience experts are involved in the design of
the study, development and implementation of study protocols,
and monitoring the study process. A group of peer-experts has
been consulted during the process of creating this cohort. They
made sure the interest and the vision of the process of recovery
from clients would be valued and integrated in this cohort.
Additionally, a small pilot study has been done with five peer-
expert students to test the length and order of the interview and
get their feedback on the questionnaires themselves. The results
have been discussed with the original group of peer-experts,
and changes to the organization of the interview were made
in cooperation with these peer-experts. Furthermore, experience
experts are present during the training of the student-researchers,
guiding them through the meaning of recovery and letting them
experience the concept, but also helping them streamline the
interview in a way that is least demanding for the participants
but without changing the validity of any of the questionnaires.
Furthermore, service users/experience experts attached to
participating teams will support the student-researchers in
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TABLE 2 | Overview of the procedures per time point.
Year 0 1 2 3 4 5 6 7 8 9 10
ReQOL X X X X X X X X X X X
I.ROC X X X X X X X X X X X
PANSS X X X X X X X X X X X
BRIEF-A X X X X X X X X X X X
SRPQ - SF X X X X X X X X X X X
LKV-51 X X X X X X
TiC-P X X X X X X




PHQ-9 X X X X X X
GAD-7 X X X X X X
ACE X
TSQ X X X X X X
MATE X X X X X X
PAM X X X X X X
BACS X X X X X X
SCT X X X X X X
CISS X X X X X X
BCIS X X X X X X
NEL X X X X X X
BRS X X X X X X
ISMI-10 X X X X X X
WHO-DAS X X X X X X
ROM X X X X X X X X X X X
GGZ KIT X X X X X X X X X X X
IHL X X X X X X X X X X X
SES X X X X X X
PE X X X X X X X X X X X
BT X X X X X X X X X X X
ReQOL, Recovering Quality of Life; I.ROC, Individual Recovery Outcome Counter; PANSS-R, Positive and Negative Symptom Scale—Remission; BRIEF-A, Behavior Rating Inventory of
Executive Function—Adult Version; SRPQ—SF, Social Role Participation Questionnaire—Short Form; LKV-51—Physical Complaints Questionnaire; TiC-P, Questionnaire on healthcare
utilization and productivity losses in patients with a psychiatric disorder; SCIL, Screener for Intelligence and Mentally Challenged; PHQ-9, Patients Health Questionnaire—Depression
Scale; GAD-7, Generalized Anxiety Disorder—Anxiety Scale; NEO-FFI, NEO Five Factor Inventory; ACE, Adverse Childhood Experiences; TSQ, Trauma Screening Questionnaire; MATE,
Measurement in the Addictions for Triage and Evaluations; PAM, Psychosis Attachment Measure; BACS, Brief Assessment of Cognition in Schizophrenia; SCT, Social Cognitive Tasks;
CISS, Coping Inventory for Stressful Situations; BCIS, Beck Cognitive Insight Scale; NEL, Netherlands Empowerment List; BRS, Brief Resilience Scale; ISMI-10, Internalized Stigma of
Mental Illness, short version; WHO-DAS 2, World Health Organization—Disability Assessment Schedule 2.0; SES, Service Engagement Scale; ROM, Routine Outcome Monitoring; GGZ
KIT, Mental Health—Cluster Index Test; IHL, Integrated Recovery List; PE, Physical Examination; BT, Blood Test; Medication, overview of taken medication in the last year; Treatment,
overview of received treatment in the last year.
developing a good rapport and giving the feedback to
the participants.
Sample Size Calculation
Personal recovery rates in schizophrenia and other psychotic
disorders are estimated to be about 14% (80). We expect to
observe recovery over time in a minimum of 10% of all subjects
over a period of 10 years and opt for a desired precision of 5%.
Precision-based sample size calculation using the formula: n =
(Z2 × P(1–P))/e2 (where Z = 1.96 for 95% CI, P is expected true
proportion, and e is half the desired precision), results in 553
participants. Expected loss to follow-up is estimated at about 15%
which gives a total of 651 participants to include.
Statistical Analysis
Primary analysis is to estimate the proportion of patients
achieving personal recovery over a period of 10 years. The
main focus will be on the interrelation of domains of recovery
and impacts of different factors on the course of recovery.
Using generalized linear mixed models, repeated measures of
ReQOL and I-ROC will be the dependent variables, time will be
the within-subjects factor and the biological, psychological and
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social determinants will be independent variables. All parameters
will be checked for outliers; data will be transformed when
necessary.Missing values will be dealt with accordingly. All (114),




For our primary analysis, we will calculate the proportion of
clients who reach personal recovery as measured by the ReQOL
and I-ROC questionnaires. Initial analysis will be based on
dichotomized scores without covariates. In additional analyses,
we model personal recovery over time. Using generalized linear
mixed models, repeated measures of ReQOL and I-ROC will be
the dependent variables, time will be the within-subjects factor
and the biological, psychological, and social determinants will be
independent variables.
Secondary Outcome
To investigate the associations between personal, clinical, societal
and functional recovery, analyses will focus on changes in
PANSS, BRIEF-A and SRPQ scores over time, respectively.
Generalized linear mixed models will be fit to explore the
course of recovery in relation to other recovery dimensions as
time-dependent co-variates.
DISCUSSION
This study aims to assess the course of personal recovery, and
to find determinants and time-dependent relationships with
symptomatic, functional, and social recovery in persons with a
psychotic disorder.
Participants with a psychotic disorder, from multiple
healthcare centers in The Netherlands, will be interviewed
every year for 10 years. Furthermore, biological, psychological
and social determinants that in previous research have been
associated with the four dimensions of recovery will be measured
over time. Ultimately, this study hopes to contribute to the
understanding of the complexity of recovery. In this study
we hope to unfold time-dependent relationships between
different forms of recovery and its determinants. Thus, (new)
interventions can be tailored to better fit the needs of people who
suffer from a psychotic disorder, so that recovery will be possible
for many more of these people.
Strengths and Limitations
Strengths of the study are the large number of participants,
long duration of follow-up, multiple assessments over
time (also when participants are not in mental health
care anymore), and the use of a broad range of biological,
psychological, and social determinants. The entire study has
been excogitated with the help of both a scientific board,
consisting of established researchers from the different
participating mental health care institutions, and a group
of service users/experience experts.
Limitations are that, since this is an observational study, it is
not intended to study intervention effects. However, the relatively
long follow-up period is expected to provide information on
time-dependent relationships. Secondly, two-yearly assessments
of secondary measures will not capture all variation details over
time. In add-on studies we hope to zoom in on the course of
these outcomes in selected sub-samples. Thirdly, despite random
selection of clients meeting the criteria, care avoiding or less
motivated clients may not be willing to participate, possibly
skewing our study population toward a more positive picture of
the process of recovery. Fourth, the inability to include people
not fluent in Dutch will limit the generalisability of this study.
As mentioned, those with a migration status might have major
social disadvantage, possibly causing the process of recovery to
be very different and more difficult. By excluding those not able
to answer the questionnaires due to language, we are unable
to get the full picture of the process for that group. Fifth, this
cohort does not take the recovery orientation per institution
or team into account. We are therefore unable to control for
the degree of recovery orientation. However, participants will be
clustered within teams. Team-level might thus reflect whether
team differences—like recovery orientation or other team-related
or organizational differences—are of influence on the process of
recovery for participants.
Lastly, all assessments mentioned above are assessments on
topics which are known to be important in the course of the
illness. Therefore, it is believed that a lot of these topics have
been discussed to some extent with the practitioner, but have not
(always) been objectified in a formal, numerical manner. Thus,
although these interviews are observational, practitioners may
influence some clinical decisions on the information gathered
from the study.
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